Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule -- Ignore unavailable to you. Want to Upgrade?

To: JZGalt who wrote (145)	1/14/1998 3:11:00 PM
From: SteveG	Read Replies (1) \| Respond to of 399

<..I don't see any great hurry to dump a class biotech because the market is terrible right now....> No argument, ARQL is a great company, but I got out yesterday as well. One of the questions that was asked at the conference was why ARQL didn't have the 4 top biotechs cos signed up. The response was that MRK does all their own, but they are working on the others. I think H&Q customers expected more by way of relationships/contracts to be announced, and were dissappointed. I bet they do great, but for me, there are better places to make a $$ (like WCII - on it's way to 80+, and SLOT on its way to 100+). Steve